Clinical Manufacturing Site Approved for Molecular Profiles - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Clinical Manufacturing Site Approved for Molecular Profiles


UK-based contract research and manufacturing organization Molecular Profiles has opened its new facility following a successful inspection from the Medicines and Healthcare products Regulatory Agency (MHRA). The Nottingham-based, pharmaceutical production site will provide clinical manufacturing capabilities.

This new facility marks a significant expansion for the company that started life as a spin-out from Nottingham University more than 15 years ago, the company reports. The investment adds six GMP suites, new laboratories, and a clinical packing area to support clients’ Phase I and II clinical trial projects.

The approval of the company’s cGMP-compliant facility follows a recent visit from Nick Clegg, Deputy Prime Minister of the UK Government, which provided £1.6m to the expansion through the regional growth fund grant. The new manufacturing site supports Molecular Profiles’ alliance with Onyx Scientific, which delivers pharmaceutical development services from drug discovery through the later phases of clinical development.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
42%
No government involvement in patient treatment or drug development.
12%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here